Comparing two ways to match insulin to meals in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older.
- You have been diagnosed with type 1 diabetes for at least one year.
- You currently take insulin with multiple daily injections (not a pump).
- You already know how to count carbohydrates (trained by a program or educator).
- Your latest HbA1c test result is between 7.5% and 11% (within 7 days before or after screening).
- You are not pregnant, and you have not had a severe low blood sugar episode or diabetic ketoacidosis in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether changing how many times you eat each day can help manage blood sugar levels in people with type 1 diabetes. You will follow a meal plan and track your blood sugar to see if fewer or more meals makes a difference.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
This study tests a wearable device that may measure insulin levels without needing blood draws. If you have type 1 diabetes, you might help researchers learn if this new sensor works for daily monitoring.
This trial tests MODI, a smartphone app that helps automatically adjust your insulin doses based on blood sugar readings from a continuous glucose monitor. The study checks if this system is safe and helps people with type 1 or type 2 diabetes manage their blood sugar better.
This study tests whether an automated insulin delivery system can manage blood sugar without telling it when you eat. It combines your existing pump and continuous glucose monitor with special software, and may reduce the need for carb counting.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.